"FB-cell Prolymphocytic Leukemia or Hairy Cell Variant vs. Splenic B-cell Lymphoma/Leukemia with Prominent Nucleoli"

June 21, 2024 | 2:00 PM ET

The webinar broadcast will be freely available to both members and non-members and the recorded presentation will be archived on the SH website for SH member-only access on demand. Allow approximately 60 minutes for the presentation and live Q&A.

Please note that while the SH Grand Rounds live stream is open to all attendees, you must first log into your member account to access recordings of past SH Grand Rounds.

This content is for educational purposes only. It is not intended to be a substitute for professional medical advice. Views expressed by individual presenters do not necessarily reflect the opinion of the Society for Hematopathology.

SH Webinar Archive

B-cell Prolymphocytic Leukemia or Hairy Cell Variant vs. Splenic B-cell Lymphoma/Leukemia with Prominent Nucleoli
Dr. Robert Seifert, Dr. James Cook & Dr. Kikkeri Naresh

Follicular Lymphoma Classification
Dr. Abner Louissaint, Dr. Rebecca L. King & Dr. Sam Sadigh

Myeloid Neoplasms with TP53 Mutation
Dr. Robert Hasserjian, Dr. Joseph Khoury & Dr. Xueyan Chen

Immunodeficiency Associated Lymphoproliferative Disorders
Dr. Elaine Jaffe, Dr. Yaso Natkunam and Dr. Elizabeth Courville

Flow Cytometric Analysis of MPAL: Update on the WHO Classification
Dr. Brent Wood

Digitalization of Hematopathology: Luxury or Necessity?
Dr. Olga Pozdnyakova

Castleman Disease: An Update
Dr. Amy Chadburn

Classification of Diffuse Large B-cell Lymphoma: Now and the Future
Dr. David Scott

How Genomics is Reshaping Classification of Acute Leukemia
Dr. Charles Mullighan

Bringing Mass Spec into the Care of Myeloma Patients
Dr. David Murray

Update on Acute Leukemia
Dr. Daniel A. Arber

VEXAS: Somatic Mutations in UBA1 predispose to Inflammation, Myelodysplasia, Myeloma, and Vacuolization of Myeloid and Erythroid Precursors.
Dr. Katherine Calvo

The Distinctive Nature of Primary Cutaneous B-cell Lymphomas – More Than Just "Counterparts“ of Nodal/Other Extranodal Lymphomas.
Steven H. Swerdlow, MD